SUMMIT European Cannabis Insights Summit 2026 — Exclusive industry intelligence Register Now
EVENT Cannabis Europa London 2026 — Europe's cannabis industry unites Get Tickets

Recent Searches

    Cannabrew CBD craft beer brand raises £200,000 via crowdfunding drive

    By

    A start-up CBD beer brand has raised over £200,000 in 24 hours via online crowdfunding.

    Cannabrew, a company which makes craft beers infused with CBD, is the brainchild of Elliot Horner and until this week the team consisted solely of him.

    But now over 200 people have a stake in the company after a surge of interest on the investment platform Seedrs.

    Horner, who is a semi-professional rugby player, founded the company after turning to CBD to deal with aches and pains from playing sport.

    The product – which is also billed as vegan and environmentally sustainable – is pitched at the growing consumer CBD market and the UK’s blossoming craft beer scene.

    Cannabrew founder Elliot Horner

    Horner told Cannabis Wealth: “I am absolutely blown away by the success of our recent campaign, I have always believed in myself and had absolute faith in the company but to fund over £200,000 and see the team increase from one to over 200 in under 24 hours is just incredible.

    “Despite little backing, we have already achieved so much in such a short space of time.

    “Now we have the capital to grow, and I am so excited for what the future holds within this company.

    “It feels as though we haven’t even touched the surface, and I can’t wait to explore the next steps.”

    The company produces three drinks at present: a session IPA and larger – fused with a 12mg dose of CBD – and a cider contain a 15mg dose.

    [activecampaign form=31]

    Sean Seddon

    The Briefing / Newsletter

    Insights
    you don't want
    to miss.

    A comprehensive, thoughtfully curated overview of the stories defining today's cannabis sector — breaking news, investigative features, expert commentary, and context-rich analysis to help you navigate events with clarity and confidence.

    • Policy & regulation
    • Markets & deals
    • Clinical & science
    Subscribe free